Using latent class analysis on a large categorical data set, researchers were able to determine unique phenotypes in a cohort of unselected patients with chronic hand eczema according to clinical, genetic, molecular, and physical factors of the affected skin.
A new study adds to the limited data on the use of alitretinoin in pediatric patients with hand eczema and finds efficacy in treatment that is similar to adults.
The largest case study, and the only study that highlights risk factors for eczema herpeticum recurrence, finds that early age of atopic dermatitis onset not only predisposes patients to eczema herpeticum but also recurrence.
Identification of patient-specific needs may support personalized, patient-centered care and shared decision making in the treatment of atopic eczema.
A transient receptor potential vanilloid type 1 inhibitor-based skin care cream improved subjective and objective parameters of perioral dermatitis.
The FDA has granted Fast Track designation to lebrikizumab for the treatment of moderate-to-severe atopic dermatitis.
Participation in 4 therapy seminars resulted in appreciable improvement in pruritus in patients with atopic dermatitis or psoriasis and may be an efficient supplementary method for managing chronic itch in these populations.
Fracture risk up with increasing eczema severity, with strongest associations for spinal, pelvic, hip fracture
Skin rather than blood is the primary source for the inflammatory and atherosclerosis/cardiovascular signature, data from this novel study suggests.
Atopic dermatitis is associated with clinically significant mental health symptoms, but nearly half of children with atopic dermatitis and severe mental health impairments may not receive mental healthcare, suggesting a critical practice gap.
